Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation—data from the prospective IVEPSA study

BACKGROUND: A specific subset of psoriasis patients is characterized by subclinical inflammatory changes. These patients frequently present with arthralgia and have a higher risk to develop psoriatic arthritis (PsA). We hypothesized that IL-17A inhibition in this subset of patients can intercept the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kampylafka, Eleni, Simon, David, d’Oliveira, Isabelle, Linz, Christina, Lerchen, Veronika, Englbrecht, Matthias, Rech, Juergen, Kleyer, Arnd, Sticherling, Michael, Schett, Georg, Hueber, Axel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659205/
https://www.ncbi.nlm.nih.gov/pubmed/31349876
http://dx.doi.org/10.1186/s13075-019-1957-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659205/
https://www.ncbi.nlm.nih.gov/pubmed/31349876
http://dx.doi.org/10.1186/s13075-019-1957-0

Ejemplares similares